// App-Quantinova.ai

P246 : Persistent burden of disease in patients with Crohn’s disease treated with biologic therapy: results from a real-world survey in the United States (US), France, Germany, Italy, Spain, and United Kingdom (5EU)

Researchers

Presenter

  • Sikirica, M

Principal Investigators

  • Lynch, J

  • Kershaw, J

  • Lukanova, R

  • Baker, S

  • Milligan, G

Medical Centers

  • Janssen, Market Access, Horsham, United States

  • Janssen Research & Development, LLC, Immunology, San Diego, CA, United States of America

  • Adelphi Real World, Bollington, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

  • Crohn's disease

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved